BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jian Zou, Jie Dong, Xiaofeng Yu. Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori EradicationHelicobacter 2009; 14(5): 449 doi: 10.1111/j.1523-5378.2009.00716.x
2
Shahrokh Mousavi, Jafar Toussy, Siamak Yaghmaie, Mehrdad Zahmatkesh. Azithromycin in one week quadruple therapy for <italic>H pylori</italic> eradication in IranWorld Journal of Gastroenterology 2006; 12(28): 4553-4556 doi: 10.3748/wjg.v12.i28.4553
3
Mohammad Minakari, Amir Hosein Davarpanah Jazi, Ahmad Shavakhi, Neda Moghareabed, Farinaz Fatahi. A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients WithHelicobacter pyloriInfectionHelicobacter 2010; 15(2): 154 doi: 10.1111/j.1523-5378.2009.00739.x
4
Saghi Riahizadeh, Reza Malekzadeh, Shahram Agah, Nasrin Zendehdel, Rasoul Sotoudehmanesh, Naser Ebrahimi-Dariani, Akram Pourshams, Homayoon Vahedi, Javad Mikaeli, Morteza Khatibian, Sadegh Massarrat. Sequential Metronidazole-Furazolidone or Clarithromycin-Furazolidone Compared to Clarithromycin-Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double-Blind Randomized Controlled TrialHelicobacter 2010; 15(6): 497 doi: 10.1111/j.1523-5378.2010.00798.x
5
Hyung Wook Kim, Gwang Ha Kim, Jong Yun Cheong, Ung Suk Yang, Seung Keun Park, Chul Soo Song, Dae Hwan Kang, Geun Am Song. <italic>H pylori</italic> eradication: A randomized prospective study of triple therapy with or without ecabet sodiumWorld Journal of Gastroenterology 2008; 14(6): 908-912 doi: 10.3748/wjg.14.908
6
A. Zullo, V. De Francesco, G. Scaccianoce, C. Hassan, A. Panarese, D. Piglionica, C. Panella, S. Morini, E. Ierardi. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: A randomised, multicentre studyDigestive and Liver Disease 2005; 37(7): 496 doi: 10.1016/j.dld.2005.01.017
7
F. DI MARIO, G. ARAGONA, N. DAL BO, L. CAVALLARO, V. MARCON, P. OLIVIERI, E. BENEDETTI, N. ORZES, R. MARIN, G. TAFNER, F. CHILOVI, R. DE BASTIANI, F. FEDRIZZI, M. FRANCESCHI, M. H. SALVAT, F. MONICA, L. PIAZZI, F. VALIANTE, U. VECCHIATI, G. M. CAVESTRO, G. COMPARATO, V. IORI, M. MAINO, G. LEANDRO, A. PILOTTO, M. RUGGE, A. FRANZE. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre studyAlimentary Pharmacology and Therapeutics 2006; 23(8): 1235 doi: 10.1111/j.1365-2036.2006.02851.x
8
Yildiran Songür, Altuğ Şenol, Ayşe Balkarli, Abdülkadir Baştürk, Süreyya Çerçi. Triple or Quadruple Tetracycline-Based Therapies Versus Standard Triple Treatment for Helicobacter pylori TreatmentThe American Journal of the Medical Sciences 2009; 338(1): 50 doi: 10.1097/MAJ.0b013e31819c7320
9
J. P. GISBERT, J.-L. GISBERT, S. MARCOS, I. JIMENEZ-ALONSO, R. MORENO-OTERO, J. M. PAJARES. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patientsAlimentary Pharmacology & Therapeutics 2007; 27(4): 346 doi: 10.1111/j.1365-2036.2007.03573.x
10
Orhan Sezgin, Engin Altınta, Erdinç Nayır, Enver Üçbilek. A Pilot Study Evaluating Sequential Administration of a PPI-Amoxicillin Followed by a PPI-Metronidazole-Tetracycline in TurkeyHelicobacter 2007; 12(6): 629 doi: 10.1111/j.1523-5378.2007.00547.x
11
Nicola de Bortoli, Giulia Leonardi, Eugenio Ciancia, Andrea Merlo, Massimo Bellini, Francesco Costa, Maria Gloria Mumolo, Angelo Ricchiuti, Fabrizio Cristiani, Stefano Santi, Mauro Rossi, Santino Marchi. Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and ProbioticsThe American Journal of Gastroenterology 2007; 102(5): 951 doi: 10.1111/j.1572-0241.2007.01085.x
12
A. Zullo, V. De Francesco, G. Scaccianoce, G. Manes, C. Efrati, C. Hassan, G. Maconi, D. Piglionica, C. Cannaviello, C. Panella, S. Morini, E. Ierardi. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre studyDigestive and Liver Disease 2007; 39(9): 806 doi: 10.1016/j.dld.2007.05.021
13
E. G. GIANNINI, C. BILARDI, P. DULBECCO, M. MAMONE, M. L. SANTI, R. TESTA, C. MANSI, V. SAVARINO. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradicationAlimentary Pharmacology and Therapeutics 2006; 23(2): 281 doi: 10.1111/j.1365-2036.2006.02756.x
14
Jie Dong, Xiao-Feng Yu, Jian Zou. Azithromycin-containing <italic>versus</italic> standard triple therapy for <italic>Helicobacter pylori</italic> eradication: A meta-analysisWorld Journal of Gastroenterology 2009; 15(48): 6102-6110 doi: 10.3748/wjg.15.6102
15
Orhan Sezgin, Engin Altıntaş, Enver Üçbilek, Anıl Tombak, Burçin Tellio?lu. Low Efficacy Rate of Moxifloxacin-Containing Helicobacter pylori Eradication Treatment: In an Observational Study in a Turkish PopulationHelicobacter 2007; 12(5): 518 doi: 10.1111/j.1523-5378.2007.00535.x
16
Peter Bytzer, Colm O'Morain. Treatment of Helicobacter pyloriHelicobacter 2005; 10(s1): 40 doi: 10.1111/j.1523-5378.2005.00333.x
17
Javier P. Gisbert. Review: Second-line rescue therapy ofHelicobacter pyloriinfectionTherapeutic Advances in Gastroenterology 2009; 2(6): 331 doi: 10.1177/1756283X09347109
18
F. Perna, A. Zullo, C. Ricci, C. Hassan, S. Morini, D. Vaira. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistanceDigestive and Liver Disease 2007; 39(11): 1001 doi: 10.1016/j.dld.2007.06.016
19
Abdurrahman Kadayifci, Hakan Buyukhatipoglu, M. Cemil Savas, Ilkay Simsek. Eradication of Helicobacter pylori with triple therapy:An epidemiologic analysis of trends in Turkey over 10 yearsClinical Therapeutics 2006; 28(11): 1960 doi: 10.1016/j.clinthera.2006.11.011
20
Francis Mégraud. Update on therapeutic options for Helicobacter pylori-related diseasesCurrent Infectious Disease Reports 2005; 7(2): 115 doi: 10.1007/s11908-005-0071-4
21
Edoardo G. Giannini, Claudio Bilardi, Pietro Dulbecco, Mario Mamone, Maria L. Santi, Roberto Testa, Carlo Mansi, Vincenzo Savarino. Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and TinidazoleJournal of Clinical Gastroenterology 2006; 40(6): 515 doi: 10.1097/00004836-200607000-00010
22
Carlos Robles-Jara, Carlos Robles-Medranda, Manuel Moncayo, Byron Landivar, Johnny Parrales. Is a 7-day <italic>Helicobater pylori</italic> treatment enough for eradication and inactivation of gastric inflammatory activity?World Journal of Gastroenterology 2008; 14(18): 2838-2843 doi: 10.3748/wjg.14.2838
23
J. P. GISBERT, M. FERNÁNDEZ-BERMEJO, J. MOLINA-INFANTE, B. PÉREZ-GALLARDO, A.-B. PRIETO-BERMEJO, J.-M. MATEOS-RODRÍGUEZ, P. ROBLEDO-ANDRÉS, G. GONZÁLEZ-GARCÍA. First-line triple therapy with levofloxacin for Helicobacter pylori eradicationAlimentary Pharmacology & Therapeutics 2007; 26(3): 495 doi: 10.1111/j.1365-2036.2007.03384.x
24
YUPING YUAN, QINYI WU, GUOXIANG CHENG, XUEFANG LIU, SIGUO LIU, JUAN LUO, AIMIN ZHANG, LI BIAN, JIANQUAN CHEN, JIAJUN LV, XIANGQIAN DONG, GANG YANG, YUNZHEN ZHU, LANQING MA. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pyloriInternational Journal of Molecular Medicine 2015; 36(2): 363 doi: 10.3892/ijmm.2015.2251
25
Hong Cheng, Fu-Lian Hu. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pyloriWorld Journal of Gastroenterology 2009; 15(7): 860-864 doi: 10.3748/wjg.15.860
26
Ya-Nan Gong, You-Ming Li, Ning-Min Yang, Hong-Zhang Li, Feng Guo, Lang Lin, Qun-Ying Wang, Jia-Kun Zhang, Zi-Zhong Ji, Ji-Bo Mao, Jun-Liang Mao, Zheng-Chao Shi, Wu-Heng Tang, Xin-Jian Zhu, Wei Shao, Xiao-Feng Zhang, Xing-Hua Wang, Yue-Feng Tong, Mi-Zu Jiang, Guang-Lan Chen, Zhi-Yong Wang, Hui-Min Tu, Guo-Fa Jiang, Jian-Sheng Wu, Xu-Peng Chen, Qiu-Long Ding, Hong Ouyang, Feng-Zhe Jin, Yan-Li Xu, Jian-Zhong Zhang. Centralized isolation of <italic>Helicobacter pylori</italic> from multiple centers and transport condition influencesWorld Journal of Gastroenterology 2015; 21(3): 944-952 doi: 10.3748/wjg.v21.i3.944
27
Jian Zou, Jie Dong, Xiao Feng Yu. Meta-Analysis: The Effect of Supplementation with Lactoferrin on Eradication Rates and Adverse Events DuringHelicobacter pyloriEradication TherapyHelicobacter 2009; 14(2): 119 doi: 10.1111/j.1523-5378.2009.00666.x
28
Javier P Gisbert. &ldquo;Rescue&rdquo; regimens after <italic>Helicobacter pylori</italic> treatment failureWorld Journal of Gastroenterology 2008; 14(35): 5385-5402 doi: 10.3748/wjg.14.5385
29
F. Iacopini, P. Crispino, O.A. Paoluzi, A. Consolazio, R. Pica, M. Rivera, D. Palladini, F. Nardi, P. Paoluzi. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradicationDigestive and Liver Disease 2005; 37(8): 571 doi: 10.1016/j.dld.2005.03.007
30
Mojgan Jalalzadeh, Morteza Nazarian, Jamshid Vafaeimanesh, Fatemeh Mirzamohammadi. Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in hemodialysis PatientsNephro-Urology Monthly 2012; 4(3): 571 doi: 10.5812/numonthly.2794